First look at The Endocrine Society's Performance-Enhancing Drugs Scientific Statement

Performance-enhancing drugs are synonymous with the names of elite athletes including Alex Rodriguez and Ryan Braun. In reality, major league athletes make up only a fraction of the nation's 3 million performance-enhancing drug users. As thousands of PED users age into their 50s, the long-term health effects are expected to become visible for the first time.

Testosterone expert Dr. Shalender Bhasin will be sharing an exclusive first look at The Endocrine Society's Performance-Enhancing Drugs Scientific Statement in New York Dec. 13. He will counter the misperception that PEDs are largely safe or that any adverse effects can be easily managing by discussing what science has already revealed about serious and even fatal effects of PED use. Journalists who attend will have an opportunity to review an embargoed copy of the statement and interview Dr. Bhasin prior to the statement's upcoming release.

Exclusive Sneak Peak at The Endocrine Society's Embargoed Performance-Enhancing Drugs Scientific Statement

Friday, December 13, 2013
12:30 p.m.

Grand Hyatt New York
Regency Conference Room, Mezzanine Level
109 East 42nd Street
New York, NY 10017

The press event will take place during The Endocrine Society's Hormones & Health Science Writers Conference. Media are invited to attend this event at no cost, although seating is limited. Breakfast and lunch will be provided by the Society. Registration and program details are posted online at


The Endocrine Society


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
The promise of RNA medicine is targeted and personalized